Goal of the analysis:
Evaluate how effectively an in-vitro diagnostic (IVD) device exchanges data with a Laboratory Information System (LIS), ensuring seamless sample management, result reporting, and quality control tracking. Identify workflow bottlenecks, interface issues, and data integrity risks that may affect laboratory efficiency and patient care.
Data required:
- Current LIS capabilities and configuration details (for example, supported communication protocols, data standards)
- IVD device interface specifications (for example, HL7, ASTM, or proprietary protocols)
- Workflow documentation for sample processing, testing, and result reporting
- Network infrastructure and IT security requirements
- Historical data on interface errors, delayed or lost results, and user complaints
- Regulatory guidelines on data traceability and electronic records (for example, CLIA, CAP, ISO 15189)
Detailed step-by-step instruction on how to conduct the analysis:
- Map the end-to-end laboratory workflow. Document each step, from sample collection and barcoding to analysis on the IVD device, results validation, and reporting in the LIS.
- Identify interface and communication points. Determine exactly where and how data transfers between the IVD device and the LIS occur, noting protocol or hardware details (for example, network ports, cables).
- Assess data formats and standards compliance. Check if both systems use compatible standards (for example, HL7 v2 messages) and if any customized mapping or middleware is required.
- Evaluate data flow and turnaround time. Determine average time intervals between sample analysis completion and result availability in the LIS, noting delays or manual steps.
- Review data validation and error handling. Investigate how each system flags and resolves inconsistent or incomplete data, including re-transmission or manual override procedures.
- Analyze security measures. Confirm that transmitted data is encrypted and that user authentication, access control, and audit trails meet regulatory and institutional requirements.
- Collect user feedback. Gather input from lab technicians and IT staff on system usability, error frequency, and any recurring pain points in daily operations.
- Identify bottlenecks or gaps. Pinpoint areas where manual workarounds, frequent data mismatches, or hardware limitations slow the workflow or risk data integrity.
- Recommend solutions. Propose software updates, middleware solutions, additional training, or protocol optimizations to improve interface reliability and overall lab efficiency.
Format of the output of analysis:
- A written workflow analysis report detailing current integration, data flow, and bottlenecks
- A process flow diagram illustrating each step of sample handling and data exchange
- A gap analysis or issues log listing interface errors, manual interventions, and their root causes
- A recommended action plan describing solutions, responsible teams, and timelines
How to interpret results:
- Smooth data exchange with minimal intervention indicates a well-configured LIS-IVD interface that saves time and reduces error risk.
- Frequent data mismatches or delayed result postings highlight integration challenges or hardware/software constraints needing remediation.
- Ongoing improvements in lab throughput, reduced manual entry, and fewer data errors confirm that the recommended optimizations are effective.
Steps a company can take to improve on this measure:
- Align the IVD interface with widely adopted data exchange standards (for example, HL7, ASTM), reducing the need for custom integrations.
- Deploy middleware solutions or lab automation systems that can bridge protocol gaps and streamline data validation.
- Provide regular training for lab and IT personnel on device connectivity features, troubleshooting, and best practices.
- Perform periodic interface audits to track error rates, network latency, and system updates, maintaining continuous alignment with evolving standards.
- Collaborate with LIS and IVD device vendors to share feedback, request feature enhancements, and ensure coordinated support for future upgrades.
Request the PDF Download of How to Analyze a Medical Devices Company
Menu of the analyses:
Table of Contents
A. Regulatory & Compliance
- Regulatory Pathway Analysis
- Regulatory Compliance and Quality Management Systems Review
- Labeling and Unique Device Identification (UDI) Compliance Assessment
- Device Classification and Product Code Analysis
- Combination Product Regulatory Strategy
- EU MDR/IVDR Compliance Gap Analysis
- MDSAP (Medical Device Single Audit Program) Readiness and Gap Analysis
- OTC vs. Prescription Device Classification Feasibility
- Reprocessing and Re-Manufacturing Compliance Assessment
- Software Update Lifecycle (IEC 62304) Compliance Review
B. Clinical & Post-Market
- Clinical Evidence Review
- Post-Market Surveillance and Vigilance
- CRO and Clinical Site Management Efficiency Analysis
- Real-World Evidence Generation Strategy for Device Performance
- Clinical Evidence Gap Analysis
- Comparative Efficacy and Safety Benchmarking vs. Standard of Care
- Field Safety Corrective Action and Recall Readiness Evaluation
- Patient Engagement and Compliance Tracking for Home-Use Devices
C. Reimbursement & Market Access
D. Product Development & Lifecycle
E. Operations & Supply Chain
F. Risk Management & Quality
G. Commercial Strategy & Marketing
H. Technology & Innovation
- Software as a Medical Device (SaMD) and Cybersecurity Risk Assessment
- Device Tracking and Traceability Program Analysis
- Human Factors Engineering and Usability Evaluation
- Material Compatibility and Biomaterial Selection Analysis
- Clinical Data Integration with Wearables and IoT Devices
- Calibration and Maintenance Program for Reusable Devices
- In-Vitro Diagnostic (IVD) Connectivity with Laboratory Information Systems (LIS) Workflow Analysis
- Remote Servicing and Maintenance Approach for Connected Medical Devices
I. Intellectual Property
J. Sustainability & Environmental Impact